2251 T/A polymorphism of the interleukin-8 gene and cancer risk: A HuGE review and meta-analysis based on 42 case-control studies

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 2831-2841

  Wang, Na ^a   Zhou, Rongmiao ^a   Wang, Chunmei ^b   Guo, Xiaoqing ^a   Chen, Zhifeng ^a   Yang, Shan ^a   Li, Yan ^a  

^a Medical University   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Association; Cancer; Interleukin 8; Meta analysis

Indexed keywords

INTERLEUKIN 8;

ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; COLORECTAL CANCER; ETHNIC DIFFERENCE; GENE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IL 8 GENE; LUNG CANCER; NASOPHARYNX CANCER; NEGRO; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; BIOLOGICAL MODEL; CASE CONTROL STUDY; GENETICS; META ANALYSIS; NEOPLASM; PROMOTER REGION; RISK; RISK FACTOR;

CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-8; MODELS, GENETIC; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84863828678     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1042-5     Document Type: Article

References (86)

1. Brat DJ, Bellail AC, Van Meir EG (2005) The role of interleukin-8, its receptors in gliomagenesis, tumoral angiogenesis. Neuro-Oncology 7(2):122-133
2. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4(7):540-550
3. Vicari AP, Caux C (2002) Chemokines in cancer. Cytokine Growth Factor Rev 13(2):143-154
4. Harada A, Sekido N, Akahoshi T et al (1994) Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56(5):559-564
5. Xie K (2001) Interleukin-8, human cancer biology. Cytokine Growth Factor Rev 12(4):375-391
6. Rollins BJ (1997) Chemokines. Blood 90(3):909-928
7. Du H, Bay BH, Mahendran R et al (2002) Endogenous expression of interleukin-8, interleukin-10 in nasopharyngeal carcinoma cells, the effect of photodynamic therapy. Int J Mol Med 10(1):73-76
8. Heinzmann A, Ahlert I, Kurz T et al (2004) Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma, respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 114(3):671-676
9. van Aken BE, Reitsma PH, Rosendaal FR (2002) Interleukin 8, venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 116(1):173-177
10. Koch AE, Polverini PJ, Kunkel SL et al (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258(5089): 1798-1801
11. Kitadai Y, Haruma K, Mukaida N et al (2000) Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res 6(7):2735-2740
12. Bendre MS, Gaddy-Kurten D, Mon-Foote T et al (2002) Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 62(19):5571-5579
13. Li A, Dubey S, Varney ML et al (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170(6): 3369-3376
14. Hull J, Rowlands K, Lockhart E et al (2004) Haplotype mapping of the bronchiolitis susceptibility locus near IL8. Hum Genet 114(3): 272-279
15. Canedo P, Castanheira-Vale AJ, Lunet N et al (2008) The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev 17(1):28-32
16. Hull J, Thomson A, Kwiatkowski D (2000) Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55(12):1023-1027
17. Hull J, Ackerman H, Isles K et al (2001) Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet 69(2):413-419
18. Taguchi A, Ohmiya N, Shirai K et al (2005) Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2487-2493
19. Lee WP, Tai DI, Lan KH et al (2005) The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 11(18):6431-6441
20. Snoussi K, Mahfoudh W, Bouaouina N et al (2010) Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer 10:283
21. Snoussi K, Mahfoudh W, Bouaouina N et al (2006) Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol 67(1-2):13-21
22. Kamali-Sarvestani E, Aliparasti MR, Atefi S (2007) Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 ?1208C/T gene polymorphisms with breast cancer. Neoplasma 54(6):484-489
23. Vogel U, Christensen J, Nexo BA et al (2007) Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis 28:427-434
24. Smith KC, Bateman AC, Fussell HM et al (2004) Cytokine gene polymorphisms, breast cancer susceptibility, prognosis. Eur J Immunogenet 31(4):167-173
25. Cacev T, Radosevic S, Krizanac S et al (2008) Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29(8):1572-1580
26. Wilkening S, Tavelin B, Canzian F et al (2008) Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis 29:1202-1206
27. Vogel U, Christensen J, Dybdahl M et al (2007) Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res 624:88-100
28. Gunter MJ, Canzian F, Landi S et al (2006) Inflammation-related gene polymorphisms, colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15(6):1126-1131
29. Theodoropoulos G, Papaconstantinou I, Felekouras E et al (2006) Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 12(31):5037-5043
30. Bo S, Dianliang Z, Hongmei Z et al (2010) Association of interleukin-8 gene polymorphism with cachexia from patients with gastric cancer. J Interferon Cytokine Res 30(1):9-14
31. Zhang L, Du C, Guo X et al (2010) Interleukin-8-251A/T polymorphism and Helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China. Mol Biol Rep 37(8):3983-3989
32. Song B, Zhang D, Wang S et al (2009) Association of interleukin-8 with cachexia from patients with low-third gastric cancer. Comp Funct Genomics 2009:212345
33. Ye BD, Kim SG, Park JH et al (2009) The interleukin-8 -251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pylori-infected Koreans. J Clin Gastroenterol 43:233-239
34. Ko KP, Park SK, Cho LY et al (2009) Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr 139:1008-1012
35. Kang JM, Kim N, Lee DH et al (2009) The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pyloriinduced gastroduodenal diseases in Korea. J Clin Gastroenterol 43(5):420-428
36. Shirai K, Ohmiya N, Taguchi A et al (2006) Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability. J Gastroenterol Hepatol 21(7):1129-1135
37. Kamali-Sarvestani E, Bazargani A, Masoudian M et al (2006) Association of H. pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 12:5205-5210
38. Lu W, Pan K, Zhang L et al (2005) Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis 26(3):631-636
39. Ohyauchi M, Imatani A, Yonechi M et al (2005) The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54(3):330-335
40. Savage SA, Abnet CC, Mark SD et al (2004) Variants of the IL8, IL8RB genes, risk for gastric cardia adenocarcinoma, esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 13(12):2251-2257
41. Crusius JB, Canzian F, Capella G et al (2008) Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 19:1894-1902
42. Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI et al (2007) Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile, interleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 7:70
43. Kamangar F, Abnet CC, Hutchinson AA et al (2006) Polymorphisms in inflammation-related genes, risk of gastric cancer (Finland). Cancer Causes Control 17(1):117-125
44. Savage SA, Hou L, Lissowska J et al (2006) Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev 15(3):589-591
45. Vogel U, Christensen J, Wallin H et al (2008) Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 639:89-100
46. Campa D, Hung RJ, Mates D et al (2005) Lack of association between -251T[A polymorphism of IL8, lung cancer risk. Cancer Epidemiol Biomarkers Prev 14(10):2457-2458
47. Campa D, Zienolddiny S, Maggini V et al (2005) Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 25(2):229-235;
48. Erratum in Carcinogenesis 26(6):1157
49. Ben Nasr H, Chahed K, Mestiri S et al (2007) Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Hum Immunol 68(9):761-769
50. Wei YS, Lan Y, Tang RG et al (2007) Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol 125(3):309-317
51. Wang MH, Helzlsouer KJ, Smith MW et al (2009) Association of IL10 and other immune response-and obesity-related genes with prostate cancer in CLUE II. Prostate 69:874-885
52. Michaud DS, Daugherty SE, Berndt SI et al (2006) Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res 66(8):4525-4530
53. Yang HP, Woodson K, Taylor PR et al (2006) Genetic variation in interleukin 8, its receptor genes, its influence on the risk, prognosis of prostate cancer among Finnish men in a large cancer prevention trial. Eur J Cancer Prev 15(3):249-253
54. McCarron SL, Edwards S, Evans PR et al (2002) Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62(12):3369-3372
55. Shimizu Y, Kondo S, Shirai A et al (2008) A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 35(3):381-389
56. Campa D, Hashibe M, Zaridze D et al (2007) Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. Cancer Causes Control 18:449-455
57. Vogel U, Christensen J, Wallin H et al (2007) Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res 617:138-146
58. van der Kuyl AC, Polstra AM, Weverling GJ et al (2004) An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi's sarcoma: a case-control study. AIDS 18:1206-1208
59. Howell WM, Turner SJ, Theaker JM et al (2003) Cytokine gene single nucleotide polymorphisms, susceptibility to, prognosis in cutaneous malignant melanoma. Eur J Immunogenet 30(6): 409-414
60. Zhang J, Dhakal IB, Lang NP et al (2010) Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk. Cancer Causes Control 21(9):1437-1444
61. Ahirwar DK, Mandhani A, Mittal RD (2010) IL-8 -251 T[A polymorphism is associated with bladder cancer susceptibility, outcome after BCG immunotherapy in a northern Indian cohort. Arch Med Res 41(2):97-103
62. Kury S, Buecher B, Robiou-du-Pont S et al (2008) Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer 8:326
63. Vairaktaris E, Yapijakis C, Serefoglou Z et al (2007) The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 33(4): 504-507
64. Landi S, Moreno V, Gioia-Patricola L et al (2003) Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 63(13):3560-3566
65. Leibovici D, Grossman HB, Dinney CP et al (2005) Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. J Clin Oncol 23(24): 5746-5756
66. Lee KM, Shen M, Chapman RS et al (2007) Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 28:1437-1441
67. Vairaktaris E, Yapijakis C, Serefoglou Z et al (2008) Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol 134(8):821-832
68. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129
69. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560
70. Begg CB, Mazumdar M(1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088-1101
71. Egger M, Davey Smith G, Schneider M et al (1997) Bias in metaanalysis detected by a simple, graphical test.BMJ315(7109):629-634
72. Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15-17
73. Zhang W, Stoehlmacher J, Park DJ et al (2005) Gene polymorphisms of epidermal growth factor receptor, its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer. Clin Colorectal Cancer 5(2): 124-131
74. Lurje G, Husain H, Power DG et al (2010) Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. Ann Oncol 21(1):78-86
75. Stocker G, Ott K, Henningsen N et al (2009) CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma. Eur J Cancer 45(18):3326-3335
76. Lurje G, Hendifar AE, Schultheis AM et al (2009) Polymorphisms in interleukin 1 beta, interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer. Pharmacogenet Genomics 19(2):95-102
77. Lurje G, Leers JM, Pohl A et al (2010) Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus. Ann Surg 251(5):857-864
78. Reyes-Gibby CC, Shete S, Yennurajalingam S et al (2009) Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage 38(6):894-902
79. Schultheis AM, Lurje G, Rhodes KE et al (2008) Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res 14(22): 7554-7563
80. Lin HC, Liu CC, Kang WY et al (2009) Influence of cytokine gene polymorphisms on prostate-specific antigen recurrence in prostate cancer after radical prostatectomy. Urol Int 83(4): 463-470
81. Wang J, Pan HF, Hu YT et al (2010) Polymorphism of IL-8 in 251 allele and gastric cancer susceptibility: a meta-analysis. Dig Dis Sci 55(7):1818-1823
82. Liu L, Zhuang W, Wang C et al (2010) Interleukin-8 -251 A/T gene polymorphism and gastric cancer susceptibility: a metaanalysis of epidemiological studies. Cytokine 50(3):328-334
83. Gao LB, Pan XM, Jia J et al (2010) IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. Eur J Cancer 46(8):1333-1343
84. Lee M, Lee Y, Cho HJ et al (2011) Copy number variations of chromosome 17p13.1 might be linked to high risk of lung cancer in heavy smokers. Mol Biol Rep. doi:10.1007/s11033-010-0672-3
85. Zhang Q, Li Y, Li X et al (2009) PARP-1 Val762Ala polymorphism, CagA? H. pylori infection, risk for gastric cancer in Han Chinese population. Mol Biol Rep 36(6):1461-1467
86. Duan S, Zhang G, Han Q et al (2010) CTLA-4 exon 1 ?49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients. Mol Biol Rep. doi:10.1007/s11033-010-0660-7